Endocrine Abstracts

Aims: To estimate the nonglycaemic effects of incretins in patients with long history of type 1 diabetes (T1D) and chronic kidney disease (CKD).Materials and methods: We examined 75 patients with a long history T1D (more than 20 years) and CKD on the different stages: 32 patients with CKD at the stages 1–4, 17 patients on haemodialysis, 11 with kidney transplantation, and 15 patients without CKD. In addition to routine methods of investigation we ha...